Human papillomavirus (HPV) is a significant cause of various cancers, including oral, anal, penile, and cervical cancers. This deadly virus does not discriminate, infecting both men and women.
In Nigeria, HPV is alarmingly common, with over 1.5 million cases reported each year. Left unaddressed, this health challenge threatens to spark a cancer epidemic, particularly among young girls who face a higher risk of developing cervical cancer.
Recognizing the urgent need to combat HPV, the Nigerian federal government, in collaboration with global partners such as UNICEF, WHO, and GAVI, is intensifying efforts to curb the spread of this virus.
What are the concerted efforts to tackle HPV and safeguard the future health of Nigerians?
The Global and Local Impact of HPV
In 2019, HPV was responsible for approximately 620,000 new cancer cases in women and 70,000 in men worldwide. By 2022, cervical cancer ranked as the fourth leading cause of cancer and cancer deaths among women. In Nigeria, cervical cancer remains a major health concern, underscoring the critical need for widespread HPV vaccination.
The United Nations Children’s Fund UNICEF has set an ambitious goal: vaccinate 80% of Nigerian girls aged 9 to 14 by December 2024.
Achieving this target could prevent around 33,700 cases of cervical cancer, a significant stride towards reducing the burden of this disease.
National Vaccination Efforts
In October 2023, the Nigerian government, in partnership with GAVI, WHO, and UNICEF, launched the first phase of HPV vaccinations for young girls aged 9 to 14 across 16 states. The second phase is set to commence on May 27th, 2024, expanding to 21 additional states, including Oyo, Ondo, and Ekiti.
UNICEF health specialist Dr. Ijeoma Agbo confirmed the procurement of over 15 million HPV vaccines to ensure the success of this vaccination drive. However, misinformation about the vaccine poses a significant challenge to its uptake in many communities.
Overcoming Misinformation
Conspiracy theories and myths surrounding the HPV vaccine abound. Some claim it causes infertility or is a ploy to reduce the African population. Others argue that HPV is not common enough to warrant vaccination, or that the vaccine encourages promiscuity among young girls. Additionally, there are misconceptions that the vaccine offers insufficient protection and focuses solely on girls.
However, the head of disease control and immunization in Oyo State, Mrs Kudirat Bolarinwa has been actively debunking these myths. She emphasized that the vaccination program is a government initiative aimed at tackling the high rate of cervical cancer in women. Bolarinwa also revealed that HPV vaccination will become a routine immunization after the initial campaign period.
Voices from the Frontlines
Also, medical professionals like Dr. Akinwumi Akinnuoye are educating the public about HPV symptoms and the risks of avoiding vaccination.
In Lagos, vaccine recipient Damilola John who shared her reasons for getting vaccinated, expressed her commitment to encouraging her peers to do the same.
A Call to Action for Parents
Parents play a crucial role in this health initiative. Allowing young girls to receive the HPV vaccine is an essential step in protecting them against future infections and associated cancers. HPV vaccination is not merely a health intervention; it is a powerful tool for cancer prevention, offering hope for a healthier future.
By addressing the challenges and misinformation head-on, Nigeria is taking significant strides towards eradicating HPV and its devastating effects. Through continued education, vaccination campaigns, and community engagement, the country can move closer to a future free from the shadow of HPV-related cancers.
